History of the Development of Inhibitors of Angiotensin I Conversion S. H. Ferreira Section 1: Genesis and Development of Angiotensin-Converting Enzyme Inhibitors: Focus on Enalapril 15 November 2012 Pages: 1 - 5
The Renin-Angiotensin System in the Control of Systemic Arterial Pressure Artur B. RibeiroOsvaldo Kohlmann JrOswaldo L. Ramos Section 1: Genesis and Development of Angiotensin-Converting Enzyme Inhibitors: Focus on Enalapril 15 November 2012 Pages: 6 - 12
Enalapril: A Review of Human Pharmacology Hector J. GomezVincent J. CirilloJohn D. Irvin Section 1: Genesis and Development of Angiotensin-Converting Enzyme Inhibitors: Focus on Enalapril 15 November 2012 Pages: 13 - 24
Cardiovascular Pathophysiology of Essential Hypertension: A Clue to Therapy Franz H. MesserliHector O. Ventura Section 1: Genesis and Development of Angiotensin-Converting Enzyme Inhibitors: Focus on Enalapril 15 November 2012 Pages: 25 - 34
Enalapril in Essential Hypertension Jaime Herrera-AcostaHéctor Pérez-GrovasJaime Arriaga Section 1: Genesis and Development of Angiotensin-Converting Enzyme Inhibitors: Focus on Enalapril 15 November 2012 Pages: 35 - 46
General Discussion J. A. F. Ramires Section 1: Genesis and Development of Angiotensin-Converting Enzyme Inhibitors: Focus on Enalapril 15 November 2012 Pages: 47 - 48
Natriuretic Effect and Changes in Renal Haemodynamics Induced by Enalapril in Essential Hypertension R. A. SánchezE. MarcóL. I. Moledo Section 2: Enalapril: Pharmacodynamic Findings and Therapeutic Efficacy in Hypertension and Heart Failure 15 November 2012 Pages: 49 - 58
Enalapril versus Triple-Drug Therapy in the Treatment of Renovascular Hypertension Garry P. ReamsJohn H. Bauer Section 2: Enalapril: Pharmacodynamic Findings and Therapeutic Efficacy in Hypertension and Heart Failure 15 November 2012 Pages: 59 - 69
Enalapril Maleate versus Captopril Carlos R. AyersKenneth M. BakerMarcia R. Lehman Section 2: Enalapril: Pharmacodynamic Findings and Therapeutic Efficacy in Hypertension and Heart Failure 15 November 2012 Pages: 70 - 73
Effects of Enalapril on Clinical Status, Biochemistry,Exercise Performance and Haemodynamics in Heart Failure M. W. I. WebsterM. A. FitzpatrickJ. E. Wells Section 2: Enalapril: Pharmacodynamic Findings and Therapeutic Efficacy in Hypertension and Heart Failure 15 November 2012 Pages: 74 - 81
Enalapril in Hypertension and Congestive Heart Failure F. MoncloaJ. A. SromovskyR. O. Davies Section 2: Enalapril: Pharmacodynamic Findings and Therapeutic Efficacy in Hypertension and Heart Failure 15 November 2012 Pages: 82 - 89
General Discussion M. G. Nicholls Section 2: Enalapril: Pharmacodynamic Findings and Therapeutic Efficacy in Hypertension and Heart Failure 15 November 2012 Pages: 90 - 93
Summary M. G. Nicholls Section 2: Enalapril: Pharmacodynamic Findings and Therapeutic Efficacy in Hypertension and Heart Failure 15 November 2012 Pages: 94 - 96